The classical clinical picture of the antiphospholipid syndrome (APS) is characterized by
venous and arterial thromboses, fetal losses and thrombocytopenia, in the presence of …

The antiphospholipid syndrome (APS) is defined by the occurrence of venous and arterial
thromboses, often multiple, and pregnancy morbidity (mainly, recurrent fetal losses and …

Since the original description and definition of the “antiphospholipid syndrome"(APS), a
number of distinct clinical manifestations related to it have been reported. Most of these may …

Antiphospholipid syndrome (APS) is a disease characterized by venous and arterial
thromboses or spontaneous abortions and the repeated detection of antiphospholipid …

The concept of the antiphospholipid syndrome (APS), comprising venous and arterial
thrombosis, recurrent fetal loss, and thrombocytopenia, has been expanded over the years …

The antiphospholipid syndrome (APS) is an acquired thombophilia, which is characterized
by one or more thrombotic episodes and obstetric complications in the presence of …

The antiphospholipid syndrome (APS) is defined by the development of venous and/or
arterial thromboses, often multiple, and pregnancy morbidity (mainly, recurrent fetal losses) …

The term “antiphospholipid syndrome”(APS) was introduced to describe patients presenting
with a combination of recurrent arterial and venous throm-bosis, recurrent fetal losses, often …

Antiphospholipid syndrome is one of the more common acquired causes of
hypercoagulability. Its major presentations are thrombotic (arterial, venous, or …

Antiphospholipid syndrome is being increasingly recognized as a disease with a myriad of
clinical manifestations ranging from recurrent thrombosis and pregnancy morbidity to …